The Business Times
SUBSCRIBERS

Cennerv Pharma withdraws IPO plans

google-preferred-sourceAdd BT as a preferred source
Published Wed, May 22, 2019 · 09:50 PM

Singapore

WEAK demand for its shares has forced drug development firm Cennerv Pharmaceuticals to withdraw its application for an initial public offering (IPO), the company said last week.

The Singapore-based firm had lodged a draft prospectus for a listing on the Catalist board of the Singapore Exchange on March 6.

Copyright SPH Media. All rights reserved.

Reuse this contentFeedback
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More